Interpretable Prostate Cancer Detection using a Small Cohort of MRI Images
Authors: Vahid Monfared, Mohammad Hadi Gharib, Ali Sabri, Maryam Shahali, Farid Rashidi, Amit Mehta, Reza Rawassizadeh
Organizations: Department of Computer Science, Boston University Metropolitan College, Boston, MA, USA · MD, Clinical Fellow, Department of Radiology, McMaster University, Ontario, Canada · Department of Radiology, School of Medicine, 5th Azar Hospital, Radiology, Golestan University of Medical Sciences, Gorgan, Iran · MD, FRCPC, Department of Medical Imaging, Niagara Health System, Assistant Clinical Professor, Department of Radiology, McMaster University · MD, Department of Radiology, School of Medicine, 5th Azar Hospital, Golestan University of Medical Sciences, Gorgan, Golestan, Iran. · MD, FRCPC, Department of Medical Imaging, Niagara Health System, Associate Clinical Professor, Department of Radiology, McMaster University · MD, FRCPC, Department of Medical Imaging, Niagara Health System, Ontario, Canada · Adjunct clinical professor, department of radiology, McMaster University, Ontario, Canada · Center of Excellence in Precision Medicine and Digital Health, Department of Physiology, Chulalongkorn University, Thailand
Prostate cancer is a leading cause of mortality in men, yet interpretation of T2-weighted prostate MRI remains challenging due to subtle and heterogeneous lesions. We developed an interpretable framework for automatic cancer detection using a small dataset of 162 T2-weighted images (102 cancer, 60 normal), addressing data scarcity through transfer learning and augmentation. We performed a comprehensive comparison of Vision Transformers (ViT, Swin), CNNs (ResNet18), and classical methods (Logistic Regression, SVM, HOG+SVM). Transfer-learned ResNet18 achieved the best performance (90.9% accuracy, 95.2% sensitivity, AUC 0.905) with only 11M parameters, while Vision Transformers showed lower performance despite substantially higher complexity. Notably, HOG+SVM achieved comparable accuracy (AUC 0.917), highlighting the effectiveness of handcrafted features in small datasets. Unlike state-of-the-art approaches relying on biparametric MRI (T2+DWI) and large cohorts, our method achieves competitive performance using only T2-weighted images, reducing acquisition complexity and computational cost. In a reader study of 22 cases, five radiologists achieved a mean sensitivity of 67.5% (Fleiss Kappa = 0.524), compared to 95.2% for the AI model, suggesting potential for AI-assisted screening to reduce missed cancers and improve consistency. Code and data are publicly available.
Magnetic Resonance Imaging (MRI) is vital for prostate cancer (PCa) diagnosis. While advanced techniques such as Hybrid Multi-dimensional MRI (HM-MRI) have enhanced diagnostic capabilities, the significant need remains for robust, automated Artificial Intelligence (AI)-based detection methods. In this study, we combine quantitative HM-MRI of tissue composition with an AI-based neural network. We propose the Hadamard-Bias Network plus ResNet18 (HBR-Net-18), a two-stage AI framework for PCa detection. In the first stage, a Hadamard U-Net-based algorithm suppresses intensity inhomogeneities (bias fields) across six parametric HM-MRI maps generated via a Physics-Informed Autoencoder (PIA). In the second stage, a Residual Network (ResNet-18) performs patch-level classification. The framework utilizes overlapping 11-by-11 patches, incorporating both 2D intra-slice and 3D inter-slice (adjacent-slice) information to improve spatial consistency. Our experimental results demonstrate that HB-Net achieves balanced sensitivity and specificity, significantly outperforming conventional radiomics-based approaches and baseline CNN models, highlighting its potential for clinical deployment.
Emadeldeen Hamdan, Gorkem Durak, Muhammed Enes Tasci +7
Electrical and Computer Engineering Department, University of Illinois Chicago, USA · Machine and Hybrid Intelligence Lab, Northwestern University, USA · Department of Radiology, University of Chicago, USA
Many diagnostic and therapeutic clinical tasks for prostate cancer increasingly rely on multi-parametric MRI. Automating these tasks is challenging because they necessitate expert interpretations, which are difficult to scale to capitalise on modern deep learning. Although modern automated systems achieve expert-level performance in isolated tasks, their general clinical utility remains limited by the requirement of large task-specific labelled datasets. In this paper, we present ProFound, a domain-specialised vision foundation model for volumetric prostate mpMRI. ProFound is pre-trained using several variants of self-supervised approaches on a diverse, multi-institutional collection of 5,000 patients, with a total of over 22,000 unique 3D MRI volumes (over 1,800,000 2D image slices). We conducted a systematic evaluation of ProFound across a broad spectrum of 11 downstream clinical tasks on over 3,000 independent patients, including prostate cancer detection, Gleason grading, lesion localisation, gland volume estimation, zonal and surrounding structure segmentation. Experimental results demonstrate that finetuned ProFound consistently outperforms or remains competitive with state-of-the-art specialised models and existing medical vision foundation models trained/finetuned on the same data.
Yipei Wang, Yinsong Xu, Weixi Yi +11
UCL Hawkes Institute, University College London, London, UK · Department of Medical Physics and Biomedical Engineering, University College London, London, UK · School of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China +11
Artificial intelligence (AI) analysis of micro-ultrasound (μUS) has shown promise for prostate cancer (PCa) detection. However, most existing AI methods focus on the analysis of single μUS images in isolation. By contrast, expert μUS readers typically assess a full recorded video study, which provides three-dimensional context, to improve PCa detection compared to single-frame analysis. Inspired by this clinical workflow, we propose Compass, a novel AI methodology which models a μUS study as a stream of 2D images. Compass jointly integrates rotational sweep videos of the prostate with μUS frames acquired at the moment of biopsy, and performs evidence aggregation across the study using a transformer conditioned on the probe's rotational angle. Finally, a decoder head predicts frame-level and study-level risk scores for the patient. The model is trained and evaluated using a multi-center clinical trial dataset of μUS studies, including continuous rotational scans of the prostate and videos captured during biopsy acquisition. We compare the proposed method to baseline AI methods from the literature and to risk scores provided by clinical experts. Our framework shows strong performance, highlighting the value of multi-view context for μUS PCa detection, and providing a potentially powerful tool to complement human expertise in μUS-based PCa diagnosis. Our code is available at: https://github.com/mharmanani/Compass.
Paul F. R. Wilson, Mohamed Harmanani, Zhuoxin Guo +6
Queen’s University, Kingston, Canada · Vector Institute, Toronto, Canada · University of British Columbia, Vancouver, Canada +3